Skip to content

VR-based Dexterity Training in MS

Home-based Virtual Reality (VR) Headset-based Dexterity Training in Multiple Sclerosis: a Randomized-controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07193602
Enrollment
60
Registered
2025-09-26
Start date
2026-05-01
Completion date
2028-05-01
Last updated
2026-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Headset-based dexterity training, Multiple Sclerosis

Brief summary

The aim of the study is to investigate if a specifically developed home-based dexterity training intervention using a Virtual Reality (VR) Headset (Meta quest 2) improves impaired manual dexterity in persons with multiple sclerosis.

Detailed description

Subjects will be recruited during regular visits at the MS centre of the Luzerner Kantonsspital, Switzerland or at the Department of Neurology of the University Hospital Basel. Ethical approval will be obtained, and the trial will be registered in the clinicaltrials.gov database. Patients must sign informed consent prior to study entry (=Screening). If patients are eligible at screening as defined in the Inclusion- and Exclusion criteria, all primary and secondary outcome measurements will be performed at Baseline. Subjects will be randomized 1:1 in Group 1 (Training intervention) or Group 2 (Sham-Intervention) and instructed into the respective training. After 4 weeks of training, all primary and secondary outcome measurements will be repeated, and the study ends.

Interventions

DEVICEVR-based dexterity training in MS

Training of limited manual dexterity in people with multiple sclerosis through a specially developed home-based dexterity training programm using a virtual headset

OTHERmediation program

Sham Training is the comparator. The Sham group is performing a commercially available mediation programm TRIPP:

Sponsors

Christian Kamm
Lead SponsorOTHER
University Hospital, Basel, Switzerland
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Raters will not be involved in the screening and randomisation process and blinded with regard to the treatment group

Intervention model description

Prospective, randomized-controlled, home-based, multi-center, rater-blinded parallel-arm pilot study. Randomisation will be performed 1:1 to the Training-Intervention group (Group 1) or Sham group (Group 2) matched for EDSS within the last 6 month using the REDCap Randomisation Tool. The EDSS-groups are: 0-2.5 3-5.5 \> 5.5

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* MS patients with relapsing-remitting MS (RRMS), secondary-progressive MS (SPMS) or primary progressive MS (PPMS) according to the revised McDonald's criteria (Thompson et al. 2017) * Age between 18 and 75 years * Written informed consent signed by the subject must be obtained prior to study start * Patient must complain about MS related impaired manual dexterity negatively affecting ADL and/or QoL * Patients must have Arm function in multiple sclerosis questionnaire (AMSQ) score \>41

Exclusion criteria

* A relapse that started within 60 days prior to screening * Rapidly progressive disease * Any disease/condition that impaired manual dexterity besides MS * Any disease other than MS that could possibly explain the patient's signs and symptoms * Medical or psychiatric conditions that compromise the ability to comply with the protocol, or to complete the study * History of epilepsy or epileptic seizures * A history of drug abuse in the 12 months prior to screening

Design outcomes

Primary

MeasureTime frameDescription
Arm Function Score in Multiple Sclerosis Questionnaire4 weeksThe Arm Function in Multiple Sclerosis Questionnaire (AMSQ) measures manual dexterity in patients with MS. It contains 31 questions on a unidimensional scale. One final sum score is obtained with higher scores indicating more dexterous difficulties. The minimum score is 31 (no limitation) and a maximum score of 186 (extreme limitation).

Secondary

MeasureTime frameDescription
Time for completing the Nine-hole-Peg-Test (9HPT)4 weeksThe Nine-hole-Peg-Test (9HPT) is reliable (ICC values 0.80-0.99), valid and sensitive in detecting impaired dexterity in patients with MS. Patients were seated at a table with a shallow container holding nine pegs and a plastic block with nine empty holes. All pegs had to be put one at a time into the holes and then removed again one at a time into the shallow container. The time to complete the task was recorded twice on both hands and mean values were taken for each hand. No minimum or maximum cutoff values were defined. Higher completion times indicate poorer performance.
Time for completion the Coin rotation task (CRT)4 WeeksThe Coin rotation task (CRT) has been validated in assessing manual dexterity in patients with MS . Patients had to rotate a 50 Swiss Rappen coin (corresponding to a dime or 2-cent Euro coin) as fast as possible between their thumb, index and middle finger. The time to perform 20 half turns was measured twice on both hands and mean values were taken for each hand. No minimum or maximum cutoff values were defined. Higher completion times indicate poorer performance.
The highest strength value resulting from the Handheld JAMAR dynamometer4 WeeksThe Handheld JAMAR dynamometer is a reliable (ICC values 0.85 - 0.98) and valid test to measures isometric grip strength of the hands in healthy subjects and in MS patients. It is performed in an upright seating position with 90° flexion of the elbow next to the body. The highest value (kilograms force) of two maximum voluntary grip strength movements was taken for each hand. No minimum or maximum cutoff values were defined. Higher values indicate better performance.
Value resulting from the Multiple Sclerosis Impact Scale 29 (MSIS 29)4 WeeksThe Multiple Sclerosis Impact Scale 29 (MSIS 29) is valid and reliable in measuring the impact of MS on ADL. It contains 29 items comprising to a physical (MSIS-29 physical) and psychological impact scale (MSIS-29 psychological). All items are scored from 'not at all' to 'extremely' on a five-point Likert scale. The physical subscale ranges from 20 to 100, and the psychological from 9 to 45. Higher values indicate more impact.
Scores of the Electronic Neurostatus-Expanded Disability Status Scale (eEDSS) (D'Souza M et al. 2020)4 WeeksComparing the subscores of the upper extremity

Countries

Switzerland

Contacts

CONTACTChristian Kamm, Prof. Dr. med.
Christian.Kamm@luks.ch0041 41 205 29 69

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 14, 2026